Elamipretide (SS-31)
Mitochondria-targeted tetrapeptide studied in heart failure and mitochondrial disease trials.
Overview
Cardiac energetics research — not an OTC longevity peptide.
What it is
Szeto-Schiller class peptide (D-Arg-Dmt-Lys-Phe-NH2).
Mechanism (high level)
Binds cardiolipin and stabilizes mitochondrial function in preclinical and some clinical work.
Quick facts
- Dosage
- Trial-dependent IV dosing
- Route
- Intravenous in studies
- Cycle
- Intermittent infusion protocols
- Storage
- Clinical trial pharmacy
Research indications
- Heart failure
- mitochondrial disease trials
Research protocols (education)
Education-first logging template
Use PepTok to track adherence and notes; any protocol must be directed by a qualified clinician.
Interactions
Often avoided with
- Self-administration outside trial
Often combined with
- Cardiology follow-up
Peptides discussed online are not substitutes for diagnosis or prescriptions.
Side effects & safety
- Infusion reactions — monitor in medical setting.
Regulatory notes
- Investigational; not approved for general use in many regions.
FAQ
Is this a prescription?
PepTok does not provide prescriptions; it is for logging and education.
Related in catalog
Track in app
Save favorites, compare protocols, and track over time
PepTok gives you structure: stacks, reminders, notes, and progress snapshots in one place.
Educational content only. This material is not medical advice. Verify legality, sourcing, and dosing with a qualified professional.